ClinicalTrials.gov
public full text
Public Domain
Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma
This study is designed to investigate the use of omalizumab as a pretreatment for patients with persistent allergic asthma who are candidates for allergen immunotherapy (ie, allergy shots) and will test the hypothesis that omalizumab may reduce the rate of systemic reactions to immunotherapy in patients with persistent allergic asthma.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- The Effect of Omalizumab on Allergic Rhinitis Symptoms: a Comparative Study#1363212
- Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma#1172531
- Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma#1059889
- Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels#894088
- Treatment of Olfactory Dysfunction in Seasonal Allergic Rhinitis#1101990
Record · ID 1372762
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive